Hypoxic regions have been found in localized prostate adenocarcinoma (11, 12), and elevated expression of hypoxia markers, including HIF1A and vascular endothelial growth factor (VEGF), have been shown to identify patients with PCa with elevated risk of biochemical recurrence (13). This evidence concerns the gene VEGFA and posterior cortical atrophy.